Alzheimer's disease and A toxicity: from top to bottom

Nature Reviews Neuroscience

Volumn 2, Issue 8, 2001, Pages 595-598

  Small, David H ^a   Mok, Su San ^a   Bornstein, Joel C ^b  

^a Department of Pathology ^*  (Australia)

^b The University of Melbourn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; BIOLOGICAL MODEL; BRAIN CORTEX; GENETICS; HUMAN; METABOLISM; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL CORTEX; HUMANS; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NERVE NET; NEURONAL PLASTICITY; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 0035433962     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/35086072     Document Type: Article

References (87)

1. Small, D. H. & McLean, C. A. Alzheimer's disease and the amyloid P protein: what is the role of amyloid? J. Neurochem. 73, 443-449 (1999).
2. Nunan, J. & Small, D. H. Regulation of APP cleavage by a-, P- and y-secretases. FEBS Lett. 483, 6-10 (2000).
3. Scheuner, D. et al. Secreted amyloid P-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996).
4. Terry, R. D. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59, 1118-1119 (2000).
5. National Institute on Drug Abuse. Computational neuroscience at the NIH. Nature Neurosci. 3, 1161-1164 (2000).
6. McClelland, J. L. & Goddard, N. H. Considerations arising from a complementary learning systems perspective on hippocampus and neocortex. Hippocampus 6, 654-665 (1996).
7. Hopfield, J. J. Neural networks and physical systems with emergent collective computational abilities. Proc. Natl Acad. Sci. USA 79, 2554-2558 (1982).
8. Hopfield, J. J. Neurons with graded response have collective computational properties like those of two-state neurons. Proc. Natl Acad. Sci. USA 81, 3088-3092 (1984).
9. Sakurai, Y. Involvement of auditory cortical and hippocampal neurons in auditory working memory and reference memory in the rat. J. Neurosci. 14, 2606-2623 (1994).
10. Sakurai, Y. How do cell assemblies encode information in the brain? Neurosci. Biobehav. Rev. 23, 785-796 (1999).
11. Amit, D. J. & Treves, A. Associative memory neural network with low temporal spiking rates. Proc. Natl Acad. Sci. USA 86, 7871-7875 (1989).
12. Davies, C. A., Mann, D. M., Sumpter, P. Q. & Yates, P. O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78, 151-164 (1987).
13. Esiri, M. M., Pearson, R. C. A., Steele, J. E., Bowen, D. M. & Powell, T. P. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 53, 161-165 (1990).
14. Pearson, R. C. A., Esiri, M. M., Hiorns, R. W., Wilcock, G. K. & Powell, T. P. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl Acad. Sci. USA 82, 4531-4534 (1985).
15. Horn, D., Levy, N. & Ruppin, E. Neuronal-based synaptic compensation: a computational study in Alzheimer's disease. Neural Comput. 8, 1227-1243 (1996).
16. Ruppin, E. & Reggia, J. A. A neural model of memory impairment in diffuse cerebral atrophy. Br. J. Psychiatry 166, 19-28 (1995).
17. Abbott, L. F. & Nelson, S. B. Synaptic plasticity: taming the beast. Nature Neurosci. 3, 1178-1183 (2000).
18. Turrigiano, G. G. Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same. Trends Neurosci. 22, 221-227 (1999).
19. Turrigiano, G. G. & Nelson, S. G. Hebb and homeostasis in neuronal plasticity. Curr. Opin. Neurobiol. 10, 358-364 (2000).
20. Chechik, G., Meiljjson, I. & Ruppin, E. Effective neuronal learning with ineffective Hebbian learning rules. Neural Comput. 13, 817-840 (2001).
21. Horn, D., Levy, N. & Ruppin, E. Memory maintenance via neuronal regulation. Neural Comput. 10, 1-18 (1998).
22. Horn, D., Levy, N. & Ruppin, E. Neuronal regulation versus synaptic unlearning in memory maintenance mechanisms. Netw. Comput. Neural Syst. 9, 577-586 (1998).
23. Harrison, P. J., Barton, A. J., Najlerahim, A. & Pearson, R. C. A. Distribution of a kainate/AMPA receptor mRNA in normal and Alzheimer brain. Neuroreport 1, 149-152 (1990).
24. Bear, M. F. Mechanism for a sliding synaptic modification threshold. Neuron 15, 1-4 (1995).
25. Impey, S., Obrietan, K. & Storm, D. R. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11-14 (1999).
26. Di Cristo, G. et al. Requirement of ERK activation for visual cortical plasticity. Science 292, 2337-2340 (2001).
27. Markram, H., Lubke, J., Frotscher, M. & Sakmann, B. Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science 275, 213-215 (1997).
28. Van Rossum, M. C. W., Bi, G. Q. & Turrigiano, G. G. Stable hebbian learning from spike timing-dependent plasticity. J. Neurosci. 20, 8812-8821 (2000).
29. Magee, J. C. & Johnston, D. Synaptic activation of voltage- gated channels in the dendrites of hippocampal pyramidal neurons. Science 275, 209-213 (1997).
30. Kamondi, A., Acsady, L. & Buzsaki, G. Dendritic spikes are enhanced by cooperative network activity in the intact hippocampus. J. Neurosci. 18, 3919-3928 (1998).
31. Kistler, W. M. & Van Hemmen, J. L. Modeling synaptic plasticity in conjunction with the timing of pre- and postsynaptic action potentials. Neural Comput. 12, 385-405 (2000).
32. Knowles, R. B. et al. Plaque-induced neurite abnormalities: implication for disruption of neural networks in Alzheimer's disease. Proc. Natl Acad. Sci. USA 96, 5274-5279 (1999).
33. Purves, D., Voyvodic, J. T., Magrassi, L. & Yawo, H. Nerve terminal remodeling visualized in living mice by repeated examination of the same neuron. Science 238, 1122-1126 (1987).
34. Kapur, A., Yeckel, M. F., Gray, R. & Johnston, D. L-type calcium channels are required for one form of hippocampal mossy fiber LTP. J. Neurophysiol. 79, 2181-2190 (1998).
35. Segal, M. Imaging of calcium variations in living dendritic spines of cultured rat hippocampal neurons. J. Physiol. 486, 283-295 (1995).
36. Arendt, T. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 102, 723-765 (2001).
37. Phinney, A. L. et al. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 19, 8552-8559 (1999).
38. Meberg, P. J., Kossel, A. H., Williams, C. B. & Kater, S. B. Calcium-dependent alterations in dendritic architecture of hippocampal pyramidal neurons. Neuroreport 10, 639-644 (1999).
39. Mattson, M. P., Tomaselli, K. J. & Rydel, R. E. Calcium- destabilizing and neurodegenerative effects of aggregated β- amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49 (1993).
40. Mattson, M. P. et al. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376–389 (1992).
41. Weiss, J. H., Pike, C. J. & Cotman, C. W. Ca2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372–375 (1994).
42. Ueda, K., Shinohara, S., Yagami, T., Asakura, K. & Kawasaki, K. Amyloid β protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. J. Neurochem. 68, 265–271 (1997).
43. Sberna, G., Sáez-Valero, J., Beyreuther, K., Masters, C. L. & Small, D. H. The amyloid-β-protein of Alzheimer’s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69, 1177–1184 (1997).
44. Ferrer, I. et al. Phosphorylated Map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol. 11, 144–158 (2001).
45. Dineley, K. T. et al. β-Amyloid activates the mitogenactivated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer’s disease. J. Neurosci. 21, 4125–4133 (2001).
46. 1–42 binds to α7 nicotinic acetylcholine receptor with high affinity. J. Biol. Chem. 275, 5626–5632 (2000).
47. Liu, Q. S., Kawai, H. & Berg, D. K. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc. Natl Acad. Sci. USA 98, 4734–4739 (2001).
48. Pettit, D. L., Shao, Z. & Yakel, J. L. β-Amyloid1–42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21, RC120, 1–5 (2001).
49. Cheung, N. S., Small, D. H. & Livett, B. G. An amyloid peptide, βA4 25–35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells. J. Neurochem. 60, 1163–1166 (1993).
50. Kihara, T. et al. α7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block a β-amyloid-induced neurotoxicity. J. Biol. Chem. 276, 13541–13546 (2001).
51. Behl, C., Davis, J. B., Lesley, R. & Schubert, D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817–827 (1994).
52. Schubert, D. et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl Acad. Sci. USA 92, 1989–1993 (1995).
53. Pike, C. J., Ramezan-Arab, N. & Cotman, C. W. β-Amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J. Neurochem. 69, 1601–1611 (1997).
54. Hensley, K. et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 3270–3274 (1994).
55. White, A. R., Bush, A. I., Beyreuther, K., Masters, C. L. & Cappai, R. Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione. J. Neurochem. 72, 2092–2098 (1999).
56. Kawahara, M. & Kuroda, Y. Molecular mechanism of neurodegeneration induced by Alzheimer’s β-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 53, 389–397 (2000).
57. Kawahara, M., Kuroda, Y., Arispe, N. & Rojas, E. Alzheimer’s β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077–14083 (2000).
58. Mark, R. J., Hensley, K., Butterfield, D. A. & Mattson, M. P. Amyloid β-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J. Neurosci. 15, 6239–6249 (1995).
59. Lee, M. S. et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360–364 (2000).
60. Lorenzo, A. et al. Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer’s disease. Nature Neurosci. 3, 460–464 (2000).
61. Hertel, C. et al. Inhibition of the electrostatic interaction between β-amyloid peptide and membranes prevents β-amyloid-induced toxicity. Proc. Natl Acad. Sci. USA 94, 9412–9416 (1997).
62. Yaar, M. et al. Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease. J. Clin. Invest. 100, 2333–2340 (1997).
63. Kuner, P., Schubenel, R. & Hertel, C. β-Amyloid binds to p75NTR and activates NFkB in human neuroblastoma cells. J. Neurosci. Res. 54, 798–804 (1998).
64. Kane, M. D. et al. Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against β-amyloidmediated effects on 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 72, 1939–1947 (1999).
65. Zhang, Z. et al. Amyloid P-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation. J. Neurochem. 67, 1595-1606 (1996).
66. Ivins, K. J., Ivins, J. K., Sharp, J. P. & Cotman, C. W. Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by P-amyloid. J. Biol. Chem. 274, 2107-2112 (1999).
67. Ivins, K. J., Thornton, P. L., Rohn, T. T. & Cotman, C. W. Neuronal apoptosis induced by P-amyloid is mediated by caspase-8. Neurobiol. Dis. 6, 440-449 (1999).
68. Nakagawa, T. et al. Caspase-12 mediates endoplasmic- reticulum-specific apoptosis and cytotoxicity by amyloid-P. Nature 403, 98-103 (2000).
69. Troy, C. M. et al. Caspase-2 mediates neuronal cell death induced by P-amyloid. J. Neurosci. 20, 1386-1392 (2000).
70. Anderson, A. J., Pike, C. J. & Cotman, C. W. Differential induction of immediate early gene proteins in cultured neurons by P-amyloid (AP): association of c-Jun with AP- induced apoptosis. J. Neurochem. 65, 1487-1498 (1995).
71. Estus, S. et al. Aggregated amyloid-P protein induces cortical neuronal apoptosis and concomitant 'apoptotic' pattern of gene induction. J. Neurosci. 17, 7736-7745 (1997).
72. Kihiko, M. E., Tucker, H. M., Rydel, R. E. & Estus, S. c-Jun contributes to amyloid P-induced neuronal apoptosis but is not necessary for amyloid P-induced c-jun induction. J. Neurochem. 73, 2609-2612 (1999).
73. Troy, C. M. et al. P-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J. Neurochem. 77, 157-164 (2001).
74. Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R. & Park, D. S. Involvement of cell cycle elements, cyclin- dependent kinases, pRb, and E2FDP, in P-amyloid-induced neuronal death. J. Biol. Chem. 274, 19011-19016 (1999).
75. Giovanni, A. et al. E2F1 mediates death of B-amyloid- treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275, 11553-11560 (2000).
76. Loo, D. T. et al. Apoptosis is induced by P-amyloid in cultured central nervous system neurons. Proc. Natl Acad. Sci. USA 90, 7951-7955 (1993).
77. Yan, S. D. et al. RAGE and amyloid-P peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
78. Yan, S. D. et al. Amyloid-P peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 5296-5301 (1997).
79. Combs, C. K., Karlo, J. C., Kao, S. C. & Landreth, G. E. P- Amyloid stimulation of microglia and monocytes results in TNFa-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188 (2001).
80. McDonald, D. R., Bamberger, M. E., Combs, C. K. & Landreth, G. E. P-Amyloid fibrils activate parallel mitogen- activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18, 4451-4460 (1998).
81. Combs, C. K., Johnson, D. E., Cannady, S. B., Lehman, T. M. & Landreth, G. E. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of P-amyloid and prion proteins. J. Neurosci. 19, 928-939 (1999).
82. Meda, L. et al. Activation of microglial cells by P-amyloid protein and interferon-γ. Nature 374, 647-650 (1995).
83. El Khoury, J. et al. Scavenger receptor-mediated adhesion of microglia to P-amyloid fibrils. Nature 382, 716-719 (1996).
84. Paresce, D. M., Ghosh, R. N. & Maxfield, F. R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid P-protein via a scavenger receptor. Neuron 17, 553-565 (1996).
85. Akama, K. T., Albanese, C., Pestell, R. G. & Van Eldik, L. J. Amyloid P-peptide stimulates nitric oxide production in astrocytes through an NFKB-dependent mechanism. Proc. Natl Acad. Sci. USA 95, 5795-5800 (1998).
86. Akama, K. T. & Van Eldik, L. J. P-Amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin- 1P- and tumor necrosis factor-a (TNFa)-dependent, and involves a TNFa receptor-associated factor- and NFkB- inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 7918-7924 (2000).
87. Yan, S. D. et al. An intracellular protein that binds amyloid-P peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389, 689-695 (1997).